Data / Form D filings / ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc.: Form D filings
ReAlta Life Sciences, Inc., a biotechnology company in Norfolk, VA, filed 7 Form D notices with the SEC between 2018 and 2025. The latest, on May 21, 2025, reports $25 million sold of a $25 million offering to 109 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5665 LOWERY ROAD, SUITE 100, Norfolk, VA, 23502
- Phone
- (757) 901-0460
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1752530
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | New notice | $25,000,141 | $25,000,141 | 109 | Dec 18, 2024 | sec.gov | |
| May 21, 2025 | New notice | $30,000,002 | $29,929,943 | $70,059 | 149 | Nov 7, 2023 | sec.gov |
| May 21, 2025 | New notice | $11,999,998 | $11,999,998 | 85 | Feb 22, 2023 | sec.gov | |
| Sep 13, 2023 | New notice | $22,500,017 | $22,500,017 | 92 | Dec 18, 2020 | sec.gov | |
| Feb 19, 2020 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Oct 28, 2019 | New notice | $12,000,000 | $0 | $12,000,000 | 0 | Yet to occur | sec.gov |
| Sep 12, 2018 | New notice | $12,000,000 | $4,847,346 | $7,152,654 | 1 | Sep 10, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laurie Glimcher | Director | |
| David Marek | Executive Officer, Director | |
| Edward Heidt, Jr. | Director | |
| Lewis Williams | Director | |
| Andrew Miller | Director | |
| Kenji Cunnion | Executive Officer | |
| John Rickman | Executive Officer | |
| Frank Gadams | Director | |
| Paolo Martini | Executive Officer | |
| Emma Reeve | Director | |
| Mert Aktar | Director | |
| Christi Shaw | Director | |
| Neel Krishna | Executive Officer |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of May 19, 2025 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ReAlta Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.